对全球190万难治性痛风患者来说，每个月的治疗方案都是一场赌局——基础痛风药物难以起效，尿酸水平控制不好，随之而来的是关节畸形、慢性疼痛等生活质量受损；推荐药物副作用明显，且患者会逐步产生耐药性，陷入无奈停药—疾病反复发作的恶性循环。根据《全球疾病负 ...

When U.S. Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his ...

IN026 是一款针对难治性痛风的潜在 first-in-class mRNA 疗法，标志着深信生物自主研发的 mRNA-LNP 平台正式进入全新治疗类别。 专注于 RNA 药物研发的临床阶段生物科技公司深信生物今日宣布，美国食品药品监督管理局（FDA）已批准其 mRNA 候选药物 IN026 的临床试验（IND）申请。IN026 是一款针对难治性痛风的在研 mRNA 疗法。此次 IND 获批后， ...

BLOOM (TAMPA)- Dr. Kawsar Talaat, Associate Professor of Global Disease Epidemiology and Control at John’s Hopkins University, joins Casey Phillips, guest host of Bloom, guest host for Bloom, to ...

Political interference is driving biotech investment overseas, and U.S. patients and workers will pay the price.

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in ...

Many public health experts and scientists say they are stunned by Health Secretary Robert F. Kennedy Jr’s decision to cancel nearly half a billion dollars in federal funding for future vaccine ...

Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to ...